Interferon Beta-1a versus Glatiramer Acetate: Changes of Innate Immunity in a Group of Women with Multiple Sclerosis

INTRODUCTION: Multiple sclerosis (MS) is a chronic inflammatory autoimmune demyelinating disease that secondarily leads to axonal loss and associated brain atrophy. Disease-modifying drugs (DMDs) have previously been studied for their ability to affect specific immunity. This study investigates the...

Descripción completa

Detalles Bibliográficos
Autores principales: Peterka, Marek, Valis, Martin, Soucek, Ondrej, Krejsek, Jan, Sobisek, Lukáš, Sejkorova, Ilona, Klimova, Blanka, Stourac, Pavel, Pavelek, Zbysek, Novotny, Michal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Basic Investigative Studies: Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623392/
https://www.ncbi.nlm.nih.gov/pubmed/37473734
http://dx.doi.org/10.1159/000532022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623392/
https://www.ncbi.nlm.nih.gov/pubmed/37473734
http://dx.doi.org/10.1159/000532022

Ejemplares similares